Exane Derivatives’s Chemours CC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | $1.67K | Hold |
52
| – | – | ﹤0.01% | 457 |
|
2022
Q1 | $1.64K | Hold |
52
| – | – | ﹤0.01% | 767 |
|
2021
Q4 | $1.75K | Hold |
52
| – | – | ﹤0.01% | 657 |
|
2021
Q3 | $1.51K | Hold |
52
| – | – | ﹤0.01% | 804 |
|
2021
Q2 | $1.76K | Hold |
52
| – | – | ﹤0.01% | 809 |
|
2021
Q1 | $1.45K | Hold |
52
| – | – | ﹤0.01% | 684 |
|
2020
Q4 | $1.29K | Hold |
52
| – | – | ﹤0.01% | 646 |
|
2020
Q3 | $1.09K | Hold |
52
| – | – | ﹤0.01% | 586 |
|
2020
Q2 | $798 | Hold |
52
| – | – | ﹤0.01% | 545 |
|
2020
Q1 | $461 | Hold |
52
| – | – | ﹤0.01% | 581 |
|
2019
Q4 | $923 | Hold |
52
| – | – | ﹤0.01% | 525 |
|
2019
Q3 | $777 | Sell |
52
-684
| -93% | -$10.2K | ﹤0.01% | 526 |
|
2019
Q2 | $17.7K | Buy |
736
+626
| +569% | +$15K | ﹤0.01% | 407 |
|
2019
Q1 | $4.09K | Sell |
110
-133,772
| -100% | -$4.97M | ﹤0.01% | 392 |
|
2018
Q4 | $3.78M | Buy |
+133,882
| New | +$3.78M | 0.68% | 25 |
|
2018
Q3 | – | Sell |
-45,677
| Closed | -$2.03M | – | 657 |
|
2018
Q2 | $2.03M | Buy |
45,677
+45,528
| +30,556% | +$2.02M | 0.34% | 67 |
|
2018
Q1 | $6.94K | Hold |
149
| – | – | ﹤0.01% | 405 |
|
2017
Q4 | $7.45K | Hold |
149
| – | – | ﹤0.01% | 375 |
|
2017
Q3 | $7.54K | Hold |
149
| – | – | ﹤0.01% | 378 |
|
2017
Q2 | $5.65K | Hold |
149
| – | – | ﹤0.01% | 391 |
|
2017
Q1 | $5.74K | Hold |
149
| – | – | ﹤0.01% | 341 |
|
2016
Q4 | $3.29K | Hold |
149
| – | – | ﹤0.01% | 393 |
|
2016
Q3 | $2.38K | Hold |
149
| – | – | ﹤0.01% | 408 |
|
2016
Q2 | $1.23K | Hold |
149
| – | – | ﹤0.01% | 422 |
|
2016
Q1 | $1.04K | Hold |
149
| – | – | ﹤0.01% | 417 |
|
2015
Q4 | $799 | Hold |
149
| – | – | ﹤0.01% | 368 |
|
2015
Q3 | $964 | Buy |
+149
| New | +$964 | ﹤0.01% | 372 |
|